Vericel Corporation (NASDAQOTH:VCEL)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar CarlosDK (20.29) Submitted: 11/9/2012 2:47:52 PM : Outperform Start Price: $28.80 VCEL Score: -11.48

falling wedge

Featured Broker Partners


Advertisement